FNY Investment Advisers’s Maravai LifeSciences MRVI Stock Holding History

FNY Investment Advisers’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24K	Buy	+4,000	New	+$17.3K	0.01%	509
2025 Q4	–	Sell	-10,000	Closed	-$28K	–	1251
2025 Q3	$28K	Hold	10,000	–	–	0.01%	623
2025 Q2	$24K	Buy	+10,000	New	+$21K	0.01%	529
2025 Q1	–	Sell	-7,000	Closed	-$38K	–	888
2024 Q4	$38K	Buy	7,000 +6,000	+600%	+$38.6K	0.02%	362
2024 Q3	$8K	Buy	+1,000	New	+$8.64K	﹤0.01%	522

Other funds holding MRVI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

FNY Investment Advisers's MRVI Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 4,000 shares worth $24K. The stake represents 0.01% of the portfolio and ranks #509 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in MRVI as recently as Q3 2025.

FNY Investment Advisers first reported a position in MRVI in Q3 2024 and has held it in 5 quarters since. The position peaked at $38K in Q4 2024. 78 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

FNY Investment Advisers held 4,000 shares of Maravai LifeSciences worth $24K as of Q2 2026.
Maravai LifeSciences was a new FNY Investment Advisers position in Q2 2026.
Maravai LifeSciences made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #509 holding.
FNY Investment Advisers first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 5 quarters since.
FNY Investment Advisers's Maravai LifeSciences position peaked at $38K in Q4 2024.
78 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.